Indeed, both schizophrenia and MCI/AD have been associated with nAChR hypofunction (Adams and Stevens 2007; Kendziorra et al. 2011), consistent with the present finding that a nAChR agonist facilitates broad monitoring. The gene discussed is CHRNA4; the disease is schizophrenia.